Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 118Neoplasms 110Lung Neoplasms 65Colorectal Neoplasms 52Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Pancreatic Neoplasms 34Melanoma 33Ovarian Neoplasms 29Neoplastic Cells, Circulating 29Head and Neck Neoplasms 27Uterine Cervical Neoplasms 23Multiple Myeloma 20Glioma 20Colonic Neoplasms 20Sarcoma 19Carcinoma, Hepatocellular 19Leukemia, Myeloid, Acute 18Neoplasm Metastasis 17Lymphoma 15Glioblastoma 15Esophageal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Hematologic Neoplasms 14Leukemia 13Endometrial Neoplasms 13Myelodysplastic Syndromes 11Kidney Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11

Interventions

Quality of Life 2Nutritional Status 2Interviews as Topic 2sintilimab 1danvatirsen 1contrast agent BR1 1catumaxomab 1aflibercept 1Zoledronic Acid 1Vascular Access Devices 1Portasystemic Shunt, Transjugular Intrahepatic 1Octreotide 1Hyperthermic Intraperitoneal Chemotherapy 1Catheters, Indwelling 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ascites × Blood Specimen Collection × Clear all
NCT06046963 2023-09-21

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Zhejiang Cancer Hospital

Phase 2 Unknown
35 enrolled
Gastrointestinal

Ascites, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡